| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.03T | 5.92T | 5.75T | 5.67T | 5.45T | 5.31T |
| Gross Profit | 2.53T | 2.51T | 2.43T | 2.41T | 2.46T | 2.38T |
| EBITDA | 1.80T | 1.78T | 1.62T | 1.71T | 1.78T | 1.76T |
| Net Income | 712.20B | 685.68B | 637.87B | 679.11B | 672.49B | 651.50B |
Balance Sheet | ||||||
| Total Assets | 18.02T | 16.88T | 14.15T | 11.92T | 11.08T | 10.54T |
| Cash, Cash Equivalents and Short-Term Investments | 910.45B | 944.14B | 907.73B | 504.62B | 819.05B | 840.07B |
| Total Debt | 5.40T | 4.69T | 2.66T | 1.66T | 1.74T | 1.76T |
| Total Liabilities | 12.54T | 11.23T | 8.35T | 6.25T | 5.57T | 5.28T |
| Stockholders Equity | 4.97T | 5.13T | 5.25T | 5.13T | 4.98T | 4.76T |
Cash Flow | ||||||
| Free Cash Flow | 958.47B | 958.47B | 1.12T | 834.45B | 1.04T | 1.27T |
| Operating Cash Flow | 1.33T | 1.36T | 1.64T | 1.23T | 1.47T | 1.68T |
| Investing Cash Flow | -1.05T | -1.28T | -820.24B | -739.43B | -767.35B | -663.74B |
| Financing Cash Flow | -503.58B | -5.76B | -462.97B | -671.76B | -721.50B | -580.76B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥317.70B | 18.43 | 13.42% | 2.27% | 5.10% | 12.48% | |
68 Neutral | ¥10.08T | 16.09 | 13.75% | 2.85% | 3.34% | 20.36% | |
66 Neutral | ¥21.02B | 23.11 | ― | ― | 30.15% | 31.28% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
60 Neutral | ¥430.11B | 19.63 | 15.67% | 1.31% | 12.48% | 18.38% | |
60 Neutral | ¥10.31T | 19.08 | ― | 3.99% | 7.79% | 5.53% | |
56 Neutral | ¥13.33T | 9.80 | 11.22% | 3.36% | 2.10% | -9.29% |